Back to the main directory
EarningsReview / Equity
- Keeping the raise in the back pocket by BNP Paribas
- GN Store Nord - Predictability is not its strong suit by Danske Bank Equity Research
- What to expect from FY25 results due 10th Feb? by BNP Paribas
- FQ2 26 broadly in line but FY guidance withdrawn by BNP Paribas
- New Wave Group - Limited re-rating potential until investment peak is visible by Danske Bank Equity Research
- AAK - AAKing to grow again by Danske Bank Equity Research
- Banco Sabadell - Mixed results do not threaten 2027 targets, SBB is a plus by JB Capital Markets
- Covered for 2026, but what about 2027-28? by BNP Paribas
- Swedish Orphan Biovitrum - Closing 2025 with solid momentum ahead by Danske Bank Equity Research
- Troax Group - Mind the gap, expected to normalise in Q2 by Danske Bank Equity Research
- Telenor (+, NOK 172) 4Q25 Results: 4Q beat; FCF guide slightly below consensus at mid-point; 15bn buyback announced by BNP Paribas
- Nordic Semiconductor - Entering another peak year? by Danske Bank Equity Research
- Vinci; working capital surprises (again), Maersk, EU De Minimis, European air traffic, Wizz Air, SAS Airlines, US travel by BNP Paribas
- Q1-26 IMS: weak volumes, but ASP recovery by BNP Paribas
- Good execution in 2025; profit warning for 2026 by BNP Paribas
- Wallix - Vers un nouveau cycle de croissance rentable by MidCap Partners
- Same song as before, although perhaps a little out of tune by BNP Paribas
- Q4 25 - first take: Solid Q4 execution; FY 2026 guidance miss by BNP Paribas
- VINCI: RDOS. 2S’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- Strong NVST print supportive of STMN US recovery narrative by BNP Paribas
- Flowserve - Strong Power and Aftermarket, soft-ish Energy orders by BNP Paribas
- Wallix - Towards a New Cycle of Profitable Growth by MidCap Partners
- Pre release H2, FY26 guide & measures to strengthen Balance Sheet by BNP Paribas